Stay updated on CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial
Sign up to get notified when there's something new on the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page.

Latest updates to the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page
- Check2 days agoChange DetectedThe 403 Forbidden page remains in place, and its footer revision label changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check9 days agoChange DetectedA site-wide banner announces NIH’s transition to using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) and links to updates and FAQs.SummaryDifference1%

- Check16 days agoChange DetectedThe site revision label changed from v3.7.1 to v3.7.2 while the study page continued to display a 403 error.SummaryDifference0.2%

- Check23 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1. The study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check44 days agoChange DetectedA 403 Forbidden error page is now shown for the study record, replacing the previous content. This indicates access restrictions rather than an actual update to the study data.SummaryDifference19%

- Check65 days agoChange DetectedThe page shows a new revision tag v3.6.6 replacing v3.6.5, indicating an update to the page's version. This appears to be a metadata update rather than a substantive change to study details or content.SummaryDifference0.0%

Stay in the know with updates to CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page.